-
(3S)-2-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
-
ChemBase ID:
73276
-
Molecular Formular:
C25H31ClN2O5
-
Molecular Mass:
474.97704
-
Monoisotopic Mass:
474.19214978
-
SMILES and InChIs
SMILES:
c1cccc(c1)CC[C@H](N[C@H](C(=O)N1[C@@H](Cc2c(C1)cccc2)C(=O)O)C)C(=O)OCC.Cl
Canonical SMILES:
CCOC(=O)[C@@H](N[C@H](C(=O)N1Cc2ccccc2C[C@H]1C(=O)O)C)CCc1ccccc1.Cl
InChI:
InChI=1S/C25H30N2O5.ClH/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30;/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30);1H/t17-,21-,22-;/m0./s1
InChIKey:
IBBLRJGOOANPTQ-JKVLGAQCSA-N
-
Cite this record
CBID:73276 http://www.chembase.cn/molecule-73276.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(3S)-2-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
|
|
|
IUPAC Traditional name
|
quinapril hydrochloride hydrochloride
|
quinapril hydrochloride
|
|
|
Synonyms
|
Accupril
|
Quinapril hydrochloride
|
(3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid hydrochloride
|
Quinapril hydrochloride
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
3.7003553
|
H Acceptors
|
5
|
H Donor
|
2
|
LogD (pH = 5.5)
|
1.6842206
|
LogD (pH = 7.4)
|
0.31489024
|
Log P
|
1.9639356
|
Molar Refractivity
|
119.9558 cm3
|
Polarizability
|
47.146 Å3
|
Polar Surface Area
|
95.94 Å2
|
Rotatable Bonds
|
10
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Selleck Chemicals
Sigma Aldrich
Selleck Chemicals -
S2581
|
Research Area: Neurological Disease Biological Activity: Quinapril hydrochloride (Accupril) is the hydrochloride salt of quinapril that is an angiotensin-converting enzyme inhibitor with a Ki of 20 μM. Quinapril hydrochloride (Accupril) used in the treatment of hypertension and congestive heart failure. Quinapril is a prodrug. Quinapril is converted to its active metabolite, quinaprilat, in the liver. Quinapril inhibits angiotensin converting enzyme, an enzyme which catalyses the formation of angiotensin II from its precursor, angiotensin I. Angiotensin II is a powerful vasoconstrictor and increases blood pressure through a variety of mechanisms. Due to reduced angiotensin production, plasma concentrations of aldosterone are also reduced, resulting in increased excretion of sodium in the urine and increased concentrations of potassium in the blood. [1][2]References on Quinapril HCl (Accupril)[1] J Pharmacokinet Biopharm., 1998 Jun, 26(3):269-87[2] http://en.wikipedia.org/wiki/Quinapril, , |
Sigma Aldrich -
Q0632
|
Biochem/physiol Actions Quinapril is a short-acting angiotensin converting enzyme (ACE) inhibitor. |
PATENTS
PATENTS
PubChem Patent
Google Patent